![David Lonergan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Prior to joining Research Corporation Technologies in 2008, Dr. Lonergan worked as a principle advisor at LARTA Institute.
From 2001-2008, he was a director for Nanosyn Inc. Dr. Lonergan also worked for Tranzyme Pharma from 1998-2001.
Dr. Lonergan received his B.Sc in 1994 from the University of New Brunswick and his PhD in 1194 from the University of New Brunswick in Canada.
Anciens postes connus de David Lonergan
| Sociétés | Poste | Fin |
|---|---|---|
RCT BioVentures
 RCT BioVentures Investment ManagersFinance RCT BioVentures invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology, medical devices & technology sectors. It provides financing for early stage capital requirements. | Analyste en capital-investissement | 30/03/2010 |
Formation de David Lonergan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
31
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
RCT BioVentures
RCT BioVentures Investment ManagersFinance RCT BioVentures invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology, medical devices & technology sectors. It provides financing for early stage capital requirements. | Finance |
University of New Brunswick
 University of New Brunswick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
